Trustmark National Bank Trust Department’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
– Sell
-8,737
Closed -$549K – 295
2024
Q3
$549K Sell
8,737
-5,062
-37% -$295K 0.04% 194
2024
Q2
$815K Sell
13,799
-10,248
-43% -$641K 0.07% 168
2024
Q1
$1.92M Buy
24,047
+20,516
+581% +$1.57M 0.16% 111
2023
Q4
$279K Sell
3,531
-263
-7% -$18.7K 0.03% 220
2023
Q3
$265K Sell
3,794
-2,489
-40% -$176K 0.03% 219
2023
Q2
$434K Sell
6,283
-1,963
-24% -$140K 0.04% 194
2023
Q1
$613K Sell
8,246
-10,492
-56% -$880K 0.06% 182
2022
Q4
$1.75M Buy
18,738
+258
+1% +$24.9K 0.16% 106
2022
Q3
$1.76M Sell
18,480
-1,851
-9% -$183K 0.17% 100
2022
Q2
$1.88M Sell
20,331
-678
-3% -$66.2K 0.17% 100
2022
Q1
$2.13M Buy
21,009
+1,265
+6% +$133K 0.17% 100
2021
Q4
$2.04M Hold
19,744
– – 0.16% 109
2021
Q3
$1.68M Sell
19,744
-721
-4% -$60.4K 0.13% 118
2021
Q2
$1.71M Buy
20,465
+689
+3% +$56.4K 0.14% 115
2021
Q1
$1.49M Buy
19,776
+6,338
+47% +$462K 0.12% 123
2020
Q4
$918K Sell
13,438
-1,762
-12% -$115K 0.08% 133
2020
Q3
$888K Sell
15,200
-855
-5% -$53.2K 0.09% 130
2020
Q2
$1.04M Buy
16,055
+6,185
+63% +$389K 0.11% 120
2020
Q1
$586K Sell
9,870
-365
-4% -$24.4K 0.07% 145
2019
Q4
$760K Buy
10,235
+1,109
+12% +$77.9K 0.07% 136
2019
Q3
$576K Sell
9,126
-4,380
-32% -$260K 0.06% 151
2019
Q2
$736K Buy
13,506
+2,055
+18% +$111K 0.07% 134
2019
Q1
$618K Buy
11,451
+6,655
+139% +$411K 0.06% 145
2018
Q4
$314K Buy
4,796
+4,287
+842% +$320K 0.04% 186
2018
Q3
$41K Buy
+509
New +$36.4K ﹤0.01% 383
2018
Q1
– Sell
-4,968
Closed -$360K – 268
2017
Q4
$360K Buy
4,968
+2,146
+76% +$156K 0.04% 204
2017
Q3
$230K Sell
2,822
-158
-5% -$12.5K 0.03% 244
2017
Q2
$241K Sell
2,980
-90
-3% -$7.11K 0.03% 237
2017
Q1
$241K Sell
3,070
-2,014
-40% -$161K 0.03% 234
2016
Q4
$401K Sell
5,084
-2,241
-31% -$181K 0.05% 183
2016
Q3
$652K Sell
7,325
-3,550
-33% -$335K 0.08% 157
2016
Q2
$1.04M Buy
10,875
+11
+0.1% +$1.1K 0.13% 131
2016
Q1
$1.13M Buy
10,864
+3,340
+44% +$325K 0.15% 122
2015
Q4
$736K Sell
7,524
-9,551
-56% -$935K 0.1% 158
2015
Q3
$1.65M Sell
17,075
-68
-0.4% -$7.15K 0.23% 94
2015
Q2
$1.8M Buy
17,143
+140
+0.8% +$14.3K 0.24% 91
2015
Q1
$1.75M Sell
17,003
-1,497
-8% -$151K 0.23% 95
2014
Q4
$1.78M Sell
18,500
-1,000
-5% -$88.1K 0.24% 97
2014
Q3
$1.55M Buy
19,500
+30
+0.2% +$2.37K 0.22% 103
2014
Q2
$1.47M Sell
19,470
-160
-0.8% -$12.1K 0.17% 108
2014
Q1
$1.47M Buy
19,630
+2,086
+12% +$147K 0.17% 111
2013
Q4
$1.26M Buy
17,544
+837
+5% +$53.8K 0.15% 122
2013
Q3
$949K Buy
16,707
+2,085
+14% +$124K 0.12% 141
2013
Q2
$836K Buy
+14,622
New +$847K 0.11% 148

Other funds holding CVS

Trustmark National Bank Trust Department's CVS Position: Q4 2024 in Review

Trustmark National Bank Trust Department sold out of CVS Health (CVS) in Q4 2024, closing a stake of 8,737 shares — an estimated $549K sold.

Trustmark National Bank Trust Department first reported a position in CVS in Q2 2013 and held it in 44 quarters. The position peaked at $2.13M in Q1 2022. 1,671 funds tracked by Wall St. Rank hold CVS as of Q4 2024.

  • Trustmark National Bank Trust Department reported no remaining CVS Health position as of Q4 2024 after selling out during the quarter.
  • Trustmark National Bank Trust Department sold 8,737 CVS Health shares in Q4 2024, an estimated $549K.
  • Trustmark National Bank Trust Department first reported a position in CVS Health in Q2 2013 and held it in 44 quarters.
  • Trustmark National Bank Trust Department's CVS Health position peaked at $2.13M in Q1 2022.
  • 1,671 funds tracked by Wall St. Rank held CVS Health as of Q4 2024.

Based on Trustmark National Bank Trust Department's 13F filing for Q4 2024, filed 13 Feb 2025.